Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Predicting the potential effect of the JUPITER trial Howard Weintraub, MD; Dimitri Gagarin, MD
-
- The challenge of chronic ischemic heart disease Carl J. Pepine, MD, MACC
- APPROACH: Rosiglitazone not significantly better than glipizide at reducing atherosclerosis
- ATLAS TIMI 46: Rivaroxaban did not lower endpoint of death, MI, stroke, severe ischemia requiring revascularization
- COMPARE: Two preparations of carvedilol comparable in patients with HF
- Data insufficient for routine CAC screening
- FIT Heart: Special interventions did not result in better LDL reductions in family members of patients with CVD
- HF-ACTION: Exercise program yielded modest benefit for patients with HF
- JPAD: Low-dose aspirin did not prevent CV events in Japanese patients with type 2 diabetes
-
- Mass-DAC registry: Lower mortality with drug-eluting vs bare metal stents in patients with diabetes
- Mo.Ma device protects brain during carotid stenting
- New professional society aims to enhance understanding of contrast ultrasound
- Off-label use, complex trials affect renal artery stenting
- SADHART-CHF: no difference in HF events with sertraline
- SEARCH: Folic acid and B12 supplementation for homocysteine lowering did not lower cardiovascular events
- Statins in the water? Not yet
- SYNTAX: CABG best for patients not qualified for stenting
-
- Value-based health care efficiency may lead to better patient outcomes
- Vitamin E and C supplementation had no effect on major CV events
- Warfarin underused in patients with AF
- Taking time to say thanks and reflect before moving on Juan J. Rivera IV
- Joint Commission issues recommendations for anticoagulation therapy, safety
- Many FDA-approved drug trial results remain unpublished
- Cardiac CTA useful in predicting all-cause mortality in patients with CAD
- Sinus of Valsalva safe site for ablation in some patients
-
- Atherosclerosis, stent repair important areas of study to Renu Virmani, MD